The Journal of Organic Chemistry
Article
The mobile phase was 50−100% EtOAc in pet. ether to afford 13a as
Compound 15a. tert-Butyl (2-(allyloxy) ethyl) carbamate (5 g, 1
equiv, 24.87 mmol, synthesized as per an earlier reported
procedure21b) was dissolved in 50% TFA in DCM and allowed to
stir at 0 °C for 45 min. The resultant solution was stripped off and
coevaporated using toluene (2 × 20 mL) to obtain the TFA salt. The
resultant TFA salt (5 g, 1 equiv, 23.25 mmol) was dissolved in
acetonitrile (50 mL), and compound 3 (6.44 g, 1.1 equiv, 25.58
mmol) was added. Then, DIPEA (8 mL, 2 equiv, 46.511 mmol) was
added and the mixture was stirred at 50 °C in an oil bath for 5 h. The
resulting reaction mixture was cooled at room temperature and
concentrated under a vacuum, and the acquired residue was dissolved
in ethyl acetate (150 mL) and subsequently washed with KHSO4
solution and brine solution and dried (Na2SO4). The organic layer
was concentrated under a vacuum to afford 15a as a pale semisolid.
Yield 5.05 g (76%); Rf = 0.4 (silica gel TLC, 60% ethyl acetate in pet.
ether); 1H NMR (400 MHz, CDCl3) δ 929 (bs, 1 H), 8.08 (m, 1 H),
6.45 (m, 1 H), 5.87−5.80 (m, 1 H), 5.23−5.12 (m, 2 H), 3.95−3.94
(d, J = 5.3 Hz, 2 H), 3.49−3.48 (d, J = 5.3 Hz, 2 H), 3.46−3.33 (m, 2
H), 1.43 (s, 9 H), 1.08, bs, 1 H); 13C{1H} NMR (100 MHz, CDCl3)
δ 158.0, 134.5, 117.4, 82.1, 73.4, 72.2, 70.6, 69.3, 39.9, 28.2, 28.2,
1
a white solid. Yield 0.70 g (95%); mp 180−190 °C; H NMR (500
MHz, DMSO-d6) δ 11.37 (bs, 1 H), 11.07 (bs, 1 H), 7.90 (d, J = 7.4
Hz, 2 H), 7.88 (d, J = 7.4 Hz, 2 H), 7.41−7.33 (m, 10 H), 5.22−5.13
(s, 2 H), 4.69 (s, 1 H), 4.55 (s, 1 H), 4.33 (bs, 1 H), 4.28 (d, J = 6.9
Hz, 1 H), 4.23 (dd, J = 6.8, 18.8 Hz, 2 H), 4.21−4.13 (s, 1 H), 3.50−
3.49 (t, J = 6.3 Hz, 2 H), 3.36−3.24 (d, J = 5.9 Hz, 2 H), 1.49 (s, 9
H); 13C{1H} NMR (100 MHz, DMSO-d6) δ 169.9, 169.4, 167.3,
167.2, 157.3, 156.8, 154.3, 144.4, 141.2, 136.2, 136.1, 129.4, 128.9,
128.5, 128.3, 128.1, 127.5, 125.6, 125.6, 125.6, 125.6, 120.6, 120.6,
83.9, 67.8, 67.0, 66.4, 66.0, 47.3, 47.3, 47.2, 40.6, 31.8, 28.1, 28.1,
28.1; HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C36H39N6O9
699.2779; Found 699.2776; [M + Na]+ Calcd for C36H38N6O9Na
721.2598; Found 721.2592.
Compound 13b. The synthetic method of 13a was adopted to
synthesize 13b as a white solid. Yield 0.387 g (78%); mp 210−220
°C; 1H NMR (400 MHz, DMSO-d6) δ 11.26 (bs, 1 H), 7.87−7.85 (d,
J = 7.1 Hz, 2 H), 7.68−7.66 (d, J = 6.6 Hz, 2 H), 7.40−7.28 (m, 10
H), 7.16 (bs, 1 H), 6.72 (bs, 1 H), 6.33 (bs, 2 H), 5.22−5.17 (m, 1
H), 5.14−5.01 (m, 1 H), 4.87−4.84 (d, J = 12.1 Hz, 1 H), 4.28−4.16
(m, 4 H), 4.12−4.14 (m, 1 H), 4.10−3.91 (m, 2 H), 3.42 (d, J = 7.6
Hz, 1 H), 3.14 (bs, 3 H), 3.02 (m, 2 H), 2.94 (s, 3 H), 2.47 (s, 3 H),
2.41 (s, 2 H), 1.99 (m, 4 H), 1.44 (s, 6 H), 1.39 (m, 9 H), 1.34 (m, 2
H); 13C{1H} NMR (100 MHz, DMSO-d6) δ 170.0, 157.9, 156.5,
144.4, 141.2, 137.7, 135.6, 131.9, 128.9, 128.9, 128.5, 128.5, 128.5,
128.3, 128.3, 128.3, 128.1, 128.1, 128.1, 127.5, 127.5, 125.6, 124.8,
120.5, 116.7, 86.7, 67.1, 67.1, 65.8, 60.2, 52.4, 48.9, 47.1, 42.9, 38.1,
30.6, 29.4, 28.8, 28.8, 28.1, 28.1, 28.1, 28.1, 26.4, 21.5, 21.2, 19.4,
18.0, 17.6, 14.7, 14.5, 14.4, 12.7; HRMS (ESI-TOF) m/z: [M + H]+
Calcd for C53H64N9O12S 1050.4390; Found 1050.4382.
28.2; HRMS (ESI-TOF) m/z: [M
+
H]+ Calcd for
C12H23N4O4287.1714; Found 287.1710; [M + Na]+ Calcd for
C12H22N4O4Na 309.1533; Found 309.1526.
Compound 15b. 2-((tert-Butoxycarbonyl) amino) ethyl acrylate
(10 g, 1 equiv, 46.46 mmol, synthesized as per an earlier reported
procedure24c) was dissolved in 50% TFA in DCM (40 mL) and
stirred at 0 °C for 60 min, monitored by TLC. The resultant solution
was stripped off and coevaporated using toluene (2 × 20 mL) at 30
°C (to avoid undesired polymerization) to obtain TFA salt which was
carried forward for the next step without purification. The resultant
TFA salt (10 g, 1 equiv, 43.66 mmol) was dissolved in acetonitrile (80
mL), and compound 3 (12.15 g, 1.1 equiv, 4.80 mmol) was added.
Then, DIPEA (14.96 mL, 2 equiv, 8.73 mmol) was added and the
mixture was stirred at 50 °C in an oil bath for 5 h. The solution was
cooled at room temperature and concentrated under a vacuum. The
resultant residue was diluted with ethyl acetate (200 mL) and
subsequently washed with dilute KHSO4 solution and brine solution
and dried (Na2SO4). The solvent was removed under a vacuum to
afford 15b as a pale semisolid. Yield 9.90 g (75%); Rf = 0.5 (silica gel
TLC, 60% ethyl acetate in pet. ether); 1H NMR (500 MHz, CDCl3) δ
9.23 (bs, 1 H), 8.39 (bs, 2 H), 6.39−6.36 (d, J = 17.5 Hz, 1 H), 6.11
(bs, 2 H), 6.07 (m, 1 H), 5.81−5.79 (d, J = 10.7 Hz, 1 H), 4.21 (bs, 2
H), 3.47 (bs, 2 H), 1.44 (d, J = 1.5 Hz, 9 H); 13C{1H} NMR (125
MHz,CDCl3) δ 166.0, 158.1, 131.2, 128.0, 82.2, 63.5, 60.3, 49.4, 38.8,
28.1, 28.1, 28.1; HRMS (ESI-TOF) m/z: [M + H]+ Calcd for
C12H21N4O5 301.1506; Found 301.1510.
Compound 14a. Compound 12a (0.3 g, 1.05 mmol, 1 equiv) was
dissolved in DMF (5 mL), and HBTU (0.597 g, 1.57 mmol, 1.5
equiv), HOBt (212 mg, 1.57 mmol, 1.5 equiv), DIPEA (0.364 mL,
2.09 mmol, 2 equiv) were added; the mixture was stirred for 5 min at
0 °C. Ethyl (2-(((benzyloxy) carbonyl) amino) ethyl) glycinate 8
(Cbz-aeg-OEt) (0.352 g, 1.26 mmol, 1.2 equiv, synthesized as per an
earlier procedure)24b was added, and the reaction mixture was stirred
at room temperature for an additional 16 h. The resultant solution
was diluted with ice cold water, and solid precipitate was filtered
under a vacuum. The solid residue was dissolved in ethyl acetate,
subsequently washed with dilute KHSO4 solution, NaHCO3 solution,
and brine solution, dried (Na2SO4), and concentrated under vacuo to
get a white solid crude product which was purified by column
chromatography silica gel (230−400). The mobile phase was EtOAc
(50−90%) in pet. ether to afford 14a as a white solid. Yield 0.449 g
1
(79%); mp 150−160 °C; H NMR (500 MHz, DMSO-d6) δ 11.39
Compound 15c. tert-Butyl (2-acrylamidoethyl) carbamate (4.28 g,
1 equiv, 20.00 mmol, synthesized as per an earlier reported
procedure24c) was deprotected by using 50% solution of TFA in
DCM (40 mL) at ice temperature for 45 min. The resultant solution
was stripped off and coevaporated at 30 °C (to avoid undesired
polymerization) using toluene (2 × 20 mL) to obtain the TFA salt
(4.52 g, 1 equiv, 19.84 mmol) as a semisolid, which was dissolved in
acetonitrile. Compound 3 (5 g, 1 equiv, 19.84 mmol) and DIPEA (3
equiv, 10.34 mL, 59.52 mmol) were added, and the solution was
stirred at 50 °C in oil bath for 5 h. The resultant solution was cooled
at room temperature and filtered through a cotton pad, and the filtrate
was diluted with ethyl acetate (100 mL) and subsequently washed
with dilute KHSO4 solution and brine solution and dried (Na2SO4).
The solvent was removed under a vacuum to afford 15c as a white
solid. Yield 4.3 g (80%); mp 95−105 °C; Rf = 0.3 (silica gel TLC,
80% ethyl acetate in pet. ether); 1H NMR (400 MHz, CDCl3) δ 8.22
(bs, 3 H), 7.03 (bs, 2 H), 6.58 (bs, 3 H), 6.24−6.06 (m, 2 H), 5.59−
5.56 (d, J = 10.7 Hz, 1 H), 3.43−3.34 (m, 4 H), 1.44 (s, 9 H);
13C{1H} NMR (100 MHz, CDCl3) δ 171.3, 166.5, 157.8, 131.0,
126.4, 82.3, 60.5, 40.7, 39.5, 28.2, 28.2, 28.2; HRMS (ESI-TOF) m/z:
[M + H]+ Calcd for C12H22N5O4 300.1666; Found 300.1662. [Note:
δ 1.26, δ 2.05, and δ 4.12 are residual peaks of ethyl acetate.]
Compound 15d. The synthetic method of 4a was adopted to
synthesize 15d. The mono-endo-amine was synthesized via an earlier
(bs, 1 H), 11.11 (bs, 1 H), 7.37−7.22 (m, 5 H), 7.31 (bs, 1 H), 5.03−
5.01 (m, 2 H), 4.66 (s, 2 H), 4.51 (m, 1 H), 4.06 (m, 2 H), 4.04 (s, 2
H), 3.50−3.48 (d, J = 6.6 Hz, 2 H), 3.25 (bs, 2 H), 1.49 (s, 9 H), 1.17
(m, 3 H); 13C{1H} NMR (100 MHz, CDCl3) δ 169.8, 169.1, 167.0,
162.1, 157.1, 154.2, 152.9, 136.8, 128.6, 128.4, 128.2, 128.2, 86.0,
67.1, 66.8, 62.4, 61.8, 50.7, 49.3, 49.0, 42.2, 39.5, 28.1, 28.1, 28.1,
14.3; HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C24H33N6O9
549.2304; Found 549.2294.
Compound 14b. The synthetic method of 14a was adopted to
synthesize 14b as a white solid. Yield 0.307 g (72%); mp 150−160
1
°C. H NMR (400 MHz, DMSO-d6) δ 11.47 (bs, 1 H), 11.05 (bs, 1
H), 7.35−7.32 (m, 5 H), 7.19−7.01 (m, 1 H), 6.67 (bs, 1 H), 6.36
(bs, 1 H), 5.16 (m, 1 H), 5.00−4.97 (m, 2 H), 4.08 (m, 4 H), 3.43−
3.40 (dd, J = 5.7, 12.7 Hz, 2 H), 3.15−3.08 (m, 3 H), 3.02−2.96 (m,
5 H), 2.46 (s, 3 H), 2.41 (s, 3 H), 2.00−1.99 (m, 4 H), 1.47−1.46 (m,
10 H), 1.40 (s, 7 H), 1.23−1.14 (m, 3 H); 13C{1H} NMR (100 MHz,
DMSO-d6) δ 169.9, 168.9, 157.9, 156.6, 156.5, 137.7, 137.7, 134.6,
131.9, 128.8, 128.8, 128.3, 128.1, 128.1, 124.8, 116.7, 86.8, 84.0, 65.8,
65.7, 65.7, 61.4, 60.9, 60.2, 52.5, 47.7, 42.9, 38.8, 32.3, 31.4, 28.7,
28.7, 28.0, 28.0, 28.0, 25.9, 19.0, 18.0, 14.4, 14.2, 12.7; HRMS (ESI-
TOF) m/z: [M + H]+ Calcd for C41H58N9O12 900.3920; Found
900.3925; [M + Na]+ Calcd for C41H58N9O12Na 922.3740; Found
922.3735.
3192
J. Org. Chem. 2021, 86, 3186−3195